The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
November 23rd 2024
With approval, acoramaidis becomes the first agent with a label specifying near-complete stabilization of TTR.
November 18th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Patients See Remote Monitoring of Cardioverters as Beneficial
Not all the news on remote monitoring of cardiac devices was bad at the ESC Congress 2016. Though a UK study had negative findings,Italian researchers said their use reduced office and ED visits and saved patients time and money.
Sonal Bhatia from Pfizer: Consistency in Data For The Last 5 Years
Sonal Bhatia, MD, Vice President, Global Eliquis Medical Lead, Pfizer, highlighted the significance of the consistency in data over the last five years, in relation to the five-year-anniversary of her team's Aristotle study at the European Society of Cardiology 2016 (ESC).
Christoph Koenen from Bristol-Myers Squibb: The Value of Real-World Data on Eliquis Research
Emerging more frequently as part of the total evidence generated with Eliquis, real-world data allows researchers to work with larger populations to show specific reductions in major bleeding and stroke, as well.
Poushali Mukherjea from Bristol-Myers Squibb: Measures of Healthcare Delivery Are Important
Poushali Mukherjea, PhD, Executive Director, Global Medical Affairs, Bristol-Myers Squibb, noted some key takeaways from her team's 19 abstracts slated to be presented at the European Society of Cardiology Congress 2016 (ESC).
Todd Villines: Learning Valuable Lessons while Serving Overseas
One of the biggest differences between military and civilian medicine is the very real chance of being deployed to a forward military unit from a stateside appointment. Lessons from those experiences can shape a doctor's practice back in their home country.
Todd Villines: Developing Reversal Agents for Newer Anticoagulants
The development of new novel oral anticoagulants has made a definite impact in the field in a short period of time. Work is being done to bring reversal agents into the field which can work with these new medications.
Todd Villines: Getting the Latest Technology to Service Members Worldwide
In the United States the availability of the latest technology can vary depending on geographic locations in some cases. This can be a greater problem for service members stationed around the world.
Todd Villines: Specialized Training Required for Cardiac CT Scans
Cardiac CT scans can be important in diagnosing various conditions but may not be appropriate for all cardiologists to perform. As a result, with specialized training the results can be dramatically improved to help both civilian and military patients.